雜志介紹

Medcomm雜志介紹

《Medcomm》是一本以English為主的開放獲取國(guó)際優(yōu)秀期刊，中文名稱美康，本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為10.7，最新CiteScore 指數(shù)為6.7。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Hypoxia signaling in cancer: Implications for therapeutic interventions

  Author: Zhuang, Yan; Liu, Kua; He, Qinyu; Gu, Xiaosong; Jiang, Chunping; Wu, Junhua

• Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

  Author: Xia, Jie; Li, Siqin; Liu, Suling; Zhang, Lixing

• Cryo-EM structure of orphan G protein-coupled receptor GPR21

  Author: Wong, Thian-Sze; Gao, Wei; Chen, Geng; Qiu, Chen; He, Guodong; Ye, Fang; Wu, Zhangsong; Zeng, Zicheng; Du, Yang

• SOX2-positive retinal stem cells are identified in adult human pars plicata by single-cell transcriptomic analyses

  Author: Wang, Xiaotang; Fan, Wei; Xu, Zongren; Zhang, Qi; Li, Na; Li, Ruonan; Wang, Guoqing; He, Siyuan; Li, Wanqian; Liao, Dan; Zhang, Zhi; Shu, Nan; Huang, Jiaxing; Zhao, Chenyang; Hou, Shengping

英文介紹

Medcomm雜志英文介紹

MedComm is a peer-reviewed, online open access journal that publishes the pioneer works providing novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. The journal emphasizes original findings that advance the understanding of pathogenesis or improve the diagnosis and treatment of human disease. Interdisciplinary studies utilizing approaches of molecular biology, cell biology, chemistry, pharmacology or material science to address the issues of clinical, basic and translational medicines are particularly encouraged. MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques.